Loading…
MiniMed Group, Inc. is projected to rise to $16.45 by 2027, a +8% move from its current price of $15.29. MMED is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $14.91 | $15.29 | $15.69 | +0.02% |
| Jul 15 | $14.76 | $15.30 | $15.85 | +0.05% |
| Jul 16 | $14.64 | $15.30 | $15.99 | +0.07% |
| Jul 17 | $14.55 | $15.30 | $16.10 | +0.09% |
| Jul 18 | $14.46 | $15.31 | $16.20 | +0.11% |
| Jul 19 | $14.39 | $15.31 | $16.29 | +0.14% |
| Jul 20 | $14.32 | $15.31 | $16.38 | +0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.32 | $15.31 | $16.38 | +0.16% |
| Week 2 | $13.95 | $15.34 | $16.86 | +0.32% |
| Week 3 | $13.68 | $15.36 | $17.25 | +0.48% |
| Week 4 | $13.46 | $15.39 | $17.60 | +0.64% |
| Week 5 | $13.27 | $15.41 | $17.90 | +0.80% |
| Week 6 | $13.10 | $15.44 | $18.19 | +0.96% |
| Week 7 | $12.95 | $15.46 | $18.46 | +1.13% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MiniMed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services.
It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California.
MiniMed Group, Inc. (MMED) is a healthcare-focused medical technology company. The stock trades at $14.88 with a market capitalization of $4.18B and a rank of 1458. The 30-day trading range runs from $12.15 to $18.22, with near-term support at $10.80 and resistance at $15.47.
The RSI is 60, indicating neutral momentum, and annualized volatility stands at 60%. The forecast trajectory over the coming years points to a rising average price and sizable upside, culminating in a 2050 average of $53.81 with a max of $123.77 and a high long-term ROI.
A major floor 34.3% below — a decisive break under it would weaken the trend.
The nearest floor, 24.7% below — buyers have tended to step in here.
Price is pressing into resistance (2.0% away) — a breakout level to watch.
A major ceiling 20.9% above — clearing it would confirm fresh momentum.
Key MMED support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MMED market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.20 | Buy | $15.18 | Buy |
| MA 10 | $15.09 | Buy | $15.04 | Buy |
| MA 20 | $14.82 | Buy | $14.69 | Buy |
| MA 50 | $13.24 | Buy | $14.20 | Buy |
| MA 100 | — | Neutral | — | Neutral |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.79 | Neutral |
| Stoch RSI (14) | 65.42 | Neutral |
| CCI (20) | 70.99 | Neutral |
| Williams %R (14) | -16.22 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | 11.28 | Buy |
| Bollinger %B (20,2) | 0.73 | Neutral |
| Stochastic %K (14) | 83.78 | Sell |
| TRIX (15) | 0.58 | Buy |
| Awesome (5,34) | 1.17 | Buy |
| Ultimate (7,14,28) | 60.05 | Neutral |
| Momentum (10) | 1.07 | Buy |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 15.15 | Buy |
| ADX (14) | 20.33 | Buy |
| ATR (14) | 0.32 | Info |
The near-term technical picture is neutral. The RSI14 stands at 60, and the 50-day simple moving average sits at $12.95, providing context for momentum around the current level. Price action is contained within a defined band as shown by the 30-day range of $12.15 to $18.22, with notable nearby levels at $10.80 on the downside and $15.47 on the upside.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.80 | $15.29 | $20.54 | 0% | Neutral | |
| $12.62 | $16.45 | $22.95 | +8% | Neutral | |
| $14.28 | $19.39 | $28.39 | +27% | Bullish | |
| $15.32 | $21.51 | $32.71 | +41% | Bullish | |
| $15.38 | $22.27 | $34.94 | +46% | Bullish | |
| $14.51 | $21.60 | $34.84 | +41% | Bullish | |
| $14.48 | $22.13 | $36.56 | +45% | Bullish | |
| $15.28 | $23.93 | $40.42 | +57% | Bullish | |
| $16.99 | $27.24 | $46.96 | +78% | Bullish | |
| $18.55 | $30.45 | $53.47 | +99% | Bullish | |
| $21.11 | $38.53 | $73.08 | +152% | Bullish | |
| $27.87 | $61.80 | $130.88 | +304% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $10.80 | $15.29 | $18.59 | +0.00% |
| August 2026 | $13.26 | $15.81 | $19.47 | +3.43% |
| September 2026 | $12.96 | $15.61 | $19.52 | -1.28% |
| October 2026 | $12.70 | $15.43 | $19.54 | -1.17% |
| November 2026 | $12.92 | $15.81 | $20.24 | +2.47% |
| December 2026 | $12.90 | $15.89 | $20.54 | +0.48% |
Click any year to see its month-by-month MMED forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MMED to range from $10.80 to $20.54 through 2026. The $15.29 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The MMED price prediction for 2027 points to an average of $16.45 (low $12.62, high $22.95) — a potential gain of +8% on today's $15.29. A consolidation phase looks the most probable path here.
In 2028, MMED is projected to trade between $14.28 and $28.39, averaging $19.39 — a potential gain of +27% from today's $15.29. That is up +18% on the projected 2027 average. Momentum favours further upside here.
MiniMed Group, Inc.'s 2029 outlook centres on $21.51, within a $15.32 to $32.71 range. That is up +11% on the projected 2028 average. That marks a +41% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, MMED could reach as high as $34.94, with a base case around $22.27 and support toward $15.38 — roughly +46% from $15.29. Momentum favours further upside here.
Expect MMED to range from $14.51 to $34.84 through 2031. The $21.60 average target implies a +41% move from current prices. That is -3% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
The MMED price prediction for 2032 points to an average of $22.13 (low $14.48, high $36.56) — a potential gain of +45% on today's $15.29. Momentum favours further upside here.
In 2033, MMED is projected to trade between $15.28 and $40.42, averaging $23.93 — a potential gain of +57% from today's $15.29. That is up +8% on the projected 2032 average. Buyers look set to stay in control over this stretch.
MiniMed Group, Inc.'s 2034 outlook centres on $27.24, within a $16.99 to $46.96 range. That is up +14% on the projected 2033 average. That marks a +78% change versus current levels. Momentum favours further upside here.
By 2035, MMED could reach as high as $53.47, with a base case around $30.45 and support toward $18.55 — roughly +99% from $15.29. Buyers look set to stay in control over this stretch.
Expect MMED to range from $21.11 to $73.08 through 2040. The $38.53 average target implies a +152% move from current prices. That is up +27% on the projected 2035 average. Momentum favours further upside here.
The MMED price prediction for 2050 points to an average of $61.80 (low $27.87, high $130.88) — a potential gain of +304% on today's $15.29. Buyers look set to stay in control over this stretch.
Investing $1,000 in MMED today (≈ 65.402224 MMED) could be worth
$4,041.81
+$3,041.81 (+304%) by 2050 · US Dollar
Based on the average projected MMED price of $61.8 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MMEDwould be worth at today's price.
$1,000 invested in MMED on Mar 6, 2026 (≈ 54.083289 MMED) would be worth
$826.93
-$173.07 (-17.3%) today · 0.83× · US Dollar
Based on a MMED entry price of $18.49 vs. today's $15.29.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.59 | $980.76 | -1.9% |
| 1 month ago | $14.71 | $1,039.43 | +3.9% |
| 3 months ago | $13.92 | $1,098.42 | +9.8% |
| All time ago | $18.49 | $826.93 | -17.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MMED forecast.
Our base-case forecast reaches $31.00 around 2040.
Implied market cap at $31.00: $8.71B
The multi-year forecast shows a bullish trajectory with rising averages and substantial upside in later years. For 2026 the average price is $14.88 with a 0 value for ROI. In 2027 the average is $15.52 with a ROI of 4.3, and in 2028 the average is $19.03 with a ROI of 27.9.
The 2030 average is $21.30 with a ROI of 43.1, followed by 2031 at $20.54 (38.1%), 2032 at $20.21 (35.8%), and 2033 at $22.15 (48.9%). The forward years accelerate further: 2034 average $25.54 (71.6%), 2035 $28.17 (89.3%), 2040 $35.59 (139.2%), and 2050 $53.81 (261.6%). These figures imply a persistent bullish stance but are estimates and carry uncertainty and risk.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $21.30 with a max of $35.33 and a min of $13.88, delivering a ROI of 43.1 and a bullish sentiment.
Forecasts point to a bullish trajectory through 2028–2050 with rising averages and sizable ROI, including 2034 (71.6%), 2035 (89.3%), 2040 (139.2%), and 2050 (261.6%). However, near-term results can vary and these are estimates, not guarantees.
Yes—the 2050 forecast shows a max of $123.77, indicating potential upside beyond $50, but these are estimates and not guarantees.
The 30-day range is $12.15 to $18.22.
The current price is $14.88 and the market capitalization is $4.18B.
MiniMed Group, Inc. Community Discussion
0Share your MiniMed Group, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.